GeroScience
Biological aging markers are feasible in a pilot diet trial
In a four-week trial of 34 adults with metabolic syndrome, diet adherence exceeded 95 percent and participants showed no significant changes in epigenetic aging.In a four-week trial of 34 adults with metabolic syndrome, diet adherence exceeded 95 percent and participants showed no significant changes in epigenetic aging.
Randomized trial · 33 peopleInterventions
Who was studied33 adults with metabolic syndrome, 4-week intervention
What changedParticipants reported consuming tree nuts on 98.6% of days and olive oil on 96.4% of days
The catchDietary adherence relied on self-reported diaries rather than objective intake biomarkers